Yi Zhang, Xiaoxiao Lin, Lu Yao, Yingdong Cao
Journal: Reproduction, fertility, and development 2026;38(13):
PMID: 42675787
CONTEXT
Pre-eclampsia (PE) involves placental dysfunction and immune dysregulation, but the cell-type localization of tryptophan-kynurenine-nicotinamide adenine dinucleotide (Trp-Kyn-NAD+) axis-related genes in PE placentas remains unclear.
AIMS
This study aimed to localize Trp-Kyn-NAD+ axis-related expression across placental cell types and prioritize candidate axis-related markers using public transcriptomic datasets.
METHODS
The placental microarray dataset GSE75010 was used for discovery, GSE24129 for supportive external evaluation, and the single-cell RNA sequencing dataset GSE173193 for descriptive cell-type localization. Single-cell annotation, combined axis-gene localization, differential-expression and co-expression analyses, fixed four-gene model evaluation, immune-signature analysis, exploratory ligand-receptor expression scoring and transcription factor-gene co-expression analysis were performed.
KEY RESULTS
Combined single-cell analysis showed non-uniform localization of Trp-Kyn-NAD+ axis-related expression across placental cell types. Microarray-based screening prioritized AFMID, ENPP1, IDO1, and NT5E as candidate axis-related genes. The fixed four-gene model showed moderate internal discrimination, and results from the small external cohort were interpreted as supportive. Candidate genes were also associated with immune-signature variation, and ligand-receptor expression scoring identified exploratory communication-related transcriptional patterns.
CONCLUSIONS
By prioritizing AFMID, ENPP1, IDO1, and NT5E and mapping their cell-type localization, this study placed established IDO1-related evidence within a broader Trp-Kyn-NAD+ axis-related transcriptomic context. AFMID, ENPP1, and NT5E represent additional candidates for evaluation in larger cohorts and experimental systems.
IMPLICATIONS
These findings provide a cell-type-resolved transcriptomic context for prioritizing Trp-Kyn-NAD+ axis-related candidates for further validation in PE.
© 2026 The Author(s) (or their employer(s)). Published by CSIRO Publishing.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.